A detailed history of Meag Munich Ergo, Kapitalanlagegesellschaft Mb H transactions in Iqvia Holdings Inc. stock. As of the latest transaction made, Meag Munich Ergo, Kapitalanlagegesellschaft Mb H holds 130,661 shares of IQV stock, worth $26.4 Million. This represents 1.0% of its overall portfolio holdings.

Number of Shares
130,661
Previous 133,836 2.37%
Holding current value
$26.4 Million
Previous $28.3 Million 9.35%
% of portfolio
1.0%
Previous 0.96%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

SELL
$206.81 - $251.55 $656,621 - $798,671
-3,175 Reduced 2.37%
130,661 $30.9 Million
Q2 2024

Aug 01, 2024

BUY
$211.18 - $248.87 $28.3 Million - $33.3 Million
133,836 New
133,836 $28.3 Million
Q1 2020

Apr 23, 2020

SELL
$84.0 - $166.11 $247,968 - $490,356
-2,952 Closed
0 $0
Q4 2019

Jan 17, 2020

SELL
$137.59 - $155.95 $1.09 Million - $1.24 Million
-7,954 Reduced 72.93%
2,952 $453,000
Q3 2019

Oct 29, 2019

BUY
$148.25 - $161.46 $754,740 - $821,992
5,091 Added 87.55%
10,906 $1.61 Million
Q1 2019

Apr 29, 2019

SELL
$109.96 - $144.45 $471,508 - $619,401
-4,288 Reduced 42.44%
5,815 $824,000
Q4 2018

Jan 29, 2019

SELL
$105.7 - $130.35 $2.13 Million - $2.63 Million
-20,154 Reduced 66.61%
10,103 $1.14 Million
Q3 2018

Oct 23, 2018

BUY
$99.3 - $130.77 $1.78 Million - $2.34 Million
17,882 Added 144.5%
30,257 $3.94 Million
Q2 2018

Jul 17, 2018

SELL
$94.85 - $105.95 $1.3 Million - $1.45 Million
-13,706 Reduced 52.55%
12,375 $1.24 Million
Q1 2018

May 02, 2018

SELL
$95.23 - $106.01 $570,427 - $634,999
-5,990 Reduced 18.68%
26,081 $2.56 Million
Q4 2017

Jan 26, 2018

BUY
$95.0 - $108.56 $3.05 Million - $3.48 Million
32,071
32,071 $3.17 Million

Others Institutions Holding IQV

About IQVIA HOLDINGS INC.


  • Ticker IQV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 185,740,000
  • Market Cap $37.5B
  • Description
  • IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The ...
More about IQV
Track This Portfolio

Track Meag Munich Ergo, Kapitalanlagegesellschaft Mb H Portfolio

Follow Meag Munich Ergo, Kapitalanlagegesellschaft Mb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meag Munich Ergo, Kapitalanlagegesellschaft Mb H, based on Form 13F filings with the SEC.

News

Stay updated on Meag Munich Ergo, Kapitalanlagegesellschaft Mb H with notifications on news.